drugset

drugset / Trial / NCT00645255

Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects

NCT00645255 ↗

Phase 3 Terminated 466 enrolled Abbott

RandomizedParallel-groupDouble-blindTreatment

Summary

The study was designed to evaluate the long term efficacy and safety of Meridia 15 mg daily in obese subjects.

Timeline

Start: 1998-09
Primary completion: 2003-01
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Sibutramine	Small molecule	15 mg	—

Indications